Akums - Public Comps and Valuation Multiples

Akums Overview

About Akums

Akums Drugs and Pharmaceuticals Ltd a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. Its services include formulation research and development (R&D), preparation and filing of regulatory dossiers in the Indian and Outside markets, and other testing services. It is also engaged in the manufacturing and sale of branded pharmaceutical formulations and active pharmaceutical ingredients (APIs). The operates in three segments: a) Contract Development and Manufacturing Operations (CDMO), b) Active Pharmaceutical Ingredient (API), and c) Branded and Generic formulations. Key revenue is generated from Contract Development and Manufacturing Operations (CDMO).

Founded

2004

HQ

Employees

17.9K+

Website

akums.in

Sectors

Contract Research & Manufacturing
Drug Development & Therapeutics
BioTech

Financials

LTM Revenue $482M

LTM EBITDA $57.9M

EV

$743M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Akums Financials

As of September 2025, Akums reported last 12-month revenue of $482M and EBITDA of $57.9M.

In the same period, Akums generated $195M in LTM gross profit and $35.7M in net income.

See Akums valuation multiples based on analyst estimates

Akums P&L

In the most recent fiscal year, Akums reported revenue of $459M and EBITDA of $59.7M.

Akums expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Akums valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$482M	XXX	$459M	XXX	XXX	XXX
Gross Profit	$195M	XXX	$181M	XXX	XXX	XXX
Gross Margin	40%	XXX	39%	XXX	XXX	XXX
EBITDA	$57.9M	XXX	$59.7M	XXX	XXX	XXX
EBITDA Margin	12%	XXX	13%	XXX	XXX	XXX
EBIT	$42.5M	XXX	$35.0M	XXX	XXX	XXX
EBIT Margin	9%	XXX	8%	XXX	XXX	XXX
Net Profit	$35.7M	XXX	$38.1M	XXX	XXX	XXX
Net Margin	7%	XXX	8%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Akums including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $482M. EBITDA for the last twelve months was $57.9M. In the most recent fiscal year, Akums achieved $459M in revenue and $59.7M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$482M	Analyst estimates available to subscribers	$459M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$195M	Analyst estimates available to subscribers	$181M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	40.5% gross margin	Analyst estimates available to subscribers	39.4% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$57.9M	Analyst estimates available to subscribers	$59.7M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	12.0% EBITDA margin	Analyst estimates available to subscribers	13.0% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$42.5M	Analyst estimates available to subscribers	$35.0M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	8.8% EBIT margin	Analyst estimates available to subscribers	7.6% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$35.7M	Analyst estimates available to subscribers	$38.1M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	7.4% net profit margin	Analyst estimates available to subscribers	8.3% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Akums

This financial data table provides comprehensive performance metrics for Akums, a company based in India. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Akums generated $482M in revenue over the last twelve months.
The company achieved $57.9M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $195M.
Net income over the last twelve months reached $35.7M.

Fiscal Year Performance

In the most recent fiscal year, Akums reported $459M in total revenue.
Fiscal year EBITDA was $59.7M.
The company maintained a gross profit margin of 39.4% in the most recent fiscal year.
EBITDA margin for the fiscal year was 13.0%.
Net profit margin reached 8.3% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Akums. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Akums Stock Performance

Akums has current market cap of INR 70.8B (or $798M), and EV of INR 65.9B (or $743M).

Market Cap Evolution

Akums Stock Data

As of October 17, 2025, Akums's stock price is INR 462 (or $5).

See Akums trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$743M	$798M	XXX	XXX	XXX	XXX	$0.23

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Akums Valuation Multiples

Akums's trades at 1.6x EV/Revenue multiple, and 15.3x EV/EBITDA.

See valuation multiples for Akums and 15K+ public comps

Akums Financial Valuation Multiples

As of October 17, 2025, Akums has market cap of $798M and EV of $743M.

Equity research analysts estimate Akums's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Akums has a P/E ratio of 22.4x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$798M	XXX	$798M	XXX	XXX	XXX
EV (current)	$743M	XXX	$743M	XXX	XXX	XXX
EV/Revenue	1.5x	XXX	1.6x	XXX	XXX	XXX
EV/EBITDA	12.8x	XXX	15.3x	XXX	XXX	XXX
EV/EBIT	17.5x	XXX	20.4x	XXX	XXX	XXX
EV/Gross Profit	3.8x	XXX	n/a	XXX	XXX	XXX
P/E	22.4x	XXX	28.0x	XXX	XXX	XXX
EV/FCF	57.7x	XXX	34.4x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Akums Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Akums Margins & Growth Rates

Akums's last 12 month revenue growth is 10%

Akums's revenue per employee in the last FY averaged $26K, while opex per employee averaged $8K for the same period.

Akums's rule of 40 is 20% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Akums's rule of X is 36% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Akums and other 15K+ public comps

Akums Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	10%	XXX	9%	XXX	XXX	XXX
EBITDA Margin	12%	XXX	11%	XXX	XXX	XXX
EBITDA Growth	19%	XXX	22%	XXX	XXX	XXX
Rule of 40	20%	XXX	20%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	36%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$26K	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$8K	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	1%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	32%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial